- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04506593
Indiana University Gastrointestinal Motility Diagnosis Registry
Gastrointestinal Motility Diagnosis Registry
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Develop a registry (list of patients) of patients seen the clinics with motility disorders. Motility diagnosis based on billing diagnostic codes are not accurate. Motility diagnosis will be made by physicians with specialized in GI Motility, based on clinical consensus of diagnostic criteria. The information gathered from the database will be used to help promote future clinical research in the GI motility and Neurogastroenterology Unit at Indiana University School of Medicine.
Gastrointestinal motility symptoms are very common. It encompasses a wide range of problems, such as dysphagia, heartburn, nausea, emesis, food regurgitation, abdominal distension, weight loss, postprandial bloating, constipation, and diarrhea. An accurate diagnosis is essential in order to promote cost-effective treatment and future research to benefit patients with GI motility disorders
Specific Aims
- Primary Aim: Identification of patients by accurate motility diagnosis
Secondary Aims:
- To develop Patient Reported Outcome (PRO) measurements in patients with small intestinal bacterial overgrowth (SIBO)
- To develop Patient Reported Outcome (PRO) measurements in patients with gastroparesis
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Megan Jarrett
- Email: mrattin@iu.edu
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Recruiting
- Indiana University Hospital
-
Contact:
- Megan Jarrett, MBBS, MPH
- Email: mrattin@iu.edu
-
Sub-Investigator:
- Thomas V Nowak, MD
-
Principal Investigator:
- John Wo, MD
-
Sub-Investigator:
- Joel Wittles, MD
-
Sub-Investigator:
- Andrea Shin, MD
-
Sub-Investigator:
- Anita Gupta, MBBS, MPH
-
Sub-Investigator:
- Robert Siwiec, MD
-
Sub-Investigator:
- William Kessler, MD
-
Sub-Investigator:
- Toyia J Stevenson, MD
-
Sub-Investigator:
- Akira Saito, MD
-
Sub-Investigator:
- Anne Montero, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who presented to the GI outpatient clinics, in-patient consult service, and outpatient endoscopy centers within the Division of Gastroenterology and Hepatology
- Carries a diagnosis of GI motility disorder based on the diagnostic criteria listed in table
Exclusion Criteria:
1. Coexisting medical conditions that may limiting participation in clinical research trial
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Identification of patients by accurate motility diagnosis
Time Frame: .through study completion, an average of 10 years
|
Motility diagnosis will be made by physicians with specialized in GI Motility, based on consensus diagnostic criteria.
The information gathered from the database will be used to help promote future clinical development and research in GI motility disorders.
|
.through study completion, an average of 10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Reported Outcome (PRO) Measurements in Patients with Small Intestinal Bacterial Overgrowth (SIBO)
Time Frame: through study completion, an average of 10 years
|
SIBO-disease specific patient questionnaire will be compared between patients with aerodigestive tract SIBO and coliform SIBO
|
through study completion, an average of 10 years
|
Patient Reported Outcome (PRO) Measurements in Patients with Gastroparesis
Time Frame: through study completion, an average of 10 years
|
Patient Assessment of GI - Symptom (PAGI-SYM) scores will be compared between patients with emesis-predominant, dyspeptic-predominant, and regurgitation-predominant gastroparesis.
|
through study completion, an average of 10 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: John M Wo, MD, Indiana University
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Immune System Diseases
- Hypersensitivity, Immediate
- Neurologic Manifestations
- Hematologic Diseases
- Signs and Symptoms, Digestive
- Gastrointestinal Diseases
- Stomach Diseases
- Gastroenteritis
- Colonic Diseases, Functional
- Colonic Diseases
- Intestinal Diseases
- Rectal Diseases
- Hypersensitivity
- Esophageal Motility Disorders
- Deglutition Disorders
- Esophageal Diseases
- Leukocyte Disorders
- Eosinophilia
- Paralysis
- Intestinal Obstruction
- Ileus
- Vomiting
- Irritable Bowel Syndrome
- Gastroesophageal Reflux
- Constipation
- Eosinophilic Esophagitis
- Gastroparesis
- Esophagitis
- Fecal Incontinence
- Intestinal Pseudo-Obstruction
Other Study ID Numbers
- GI Database
- 1403899260 (Other Identifier: Indiana University IRB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Constipation
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
-
AbbVieIronwood Pharmaceuticals, Inc.RecruitingFunctional Constipation (FC) | Chronic Idiopathic Constipation (CIC)United States, United Kingdom, Bulgaria
-
usMIMA S.L.University of York; County Durham and Darlington NHS Foundation TrustNot yet recruitingConstipation | Constipation-predominant Irritable Bowel Syndrome | Constipation - Functional | Constipation Chronic Idiopathic | Constipation; Neurogenic
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
SK Life Science, Inc.CompletedChronic Constipation | Functional ConstipationUnited States
-
Cairo UniversityUnknownChronic Idiopathic Constipation | Functional ConstipationEgypt
-
ProgenaBiomeRecruitingConstipation | Constipation - Functional | Constipation Chronic Idiopathic | Constipation (Excl Faecal Impaction)United States
-
Chulalongkorn UniversityNot yet recruitingFunctional ConstipationThailand
-
Min-Tze LIONGDeyang People's HospitalRecruiting
-
AbbVieIronwood Pharmaceuticals, Inc.RecruitingFunctional ConstipationUnited States, Bulgaria, United Kingdom, Croatia, Germany, Hungary
Clinical Trials on no intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of PittsburghCompletedChronic Low Back PainUnited States